Showing 73 to 84 of 176 results


Stress, Obesity Magnify Pancreatic Cancer Risk in Mice: Study
UCLA research shows that stress and obesity significantly increase pancreatic cancer risk in mice, accelerating precancerous lesion growth, especially in females, by activating CREB, suggesting potential for repurposing beta-blockers for prevention.
Stress, Obesity Magnify Pancreatic Cancer Risk in Mice: Study
UCLA research shows that stress and obesity significantly increase pancreatic cancer risk in mice, accelerating precancerous lesion growth, especially in females, by activating CREB, suggesting potential for repurposing beta-blockers for prevention.
Progress
52% Bias Score


China Expands Weight Management Clinics to Combat Rising Obesity
A weight management clinic at Jincheng People's Hospital in Shanxi province, China, has expanded to combat the nation's rising obesity rates, offering personalized plans and integrating various medical fields to address individual patient needs.
China Expands Weight Management Clinics to Combat Rising Obesity
A weight management clinic at Jincheng People's Hospital in Shanxi province, China, has expanded to combat the nation's rising obesity rates, offering personalized plans and integrating various medical fields to address individual patient needs.
Progress
36% Bias Score


China Faces Looming Obesity Crisis
China's National Health Commission warns that over 70 percent of adults and 32 percent of children could be overweight or obese in five years due to lifestyle changes, resulting in a projected 22 percent of medical costs being obesity-related by 2030.
China Faces Looming Obesity Crisis
China's National Health Commission warns that over 70 percent of adults and 32 percent of children could be overweight or obese in five years due to lifestyle changes, resulting in a projected 22 percent of medical costs being obesity-related by 2030.
Progress
40% Bias Score


Trump Administration Considers Expanding AOM Coverage to Combat Obesity, Save Trillions
The Trump administration is considering expanding Medicare and Medicaid coverage of anti-obesity medications (AOMs) to save trillions in healthcare costs and combat the obesity epidemic, which is projected to cost the U.S. $14 trillion over the next decade.
Trump Administration Considers Expanding AOM Coverage to Combat Obesity, Save Trillions
The Trump administration is considering expanding Medicare and Medicaid coverage of anti-obesity medications (AOMs) to save trillions in healthcare costs and combat the obesity epidemic, which is projected to cost the U.S. $14 trillion over the next decade.
Progress
52% Bias Score


Global Obesity Crisis Projected to Affect 4.5 Billion by 2050
By 2050, 60% of adults and 31% of children globally are projected to be overweight or obese, a substantial increase from 1990, linked to rising risks of numerous diseases and placing a significant strain on healthcare systems worldwide.
Global Obesity Crisis Projected to Affect 4.5 Billion by 2050
By 2050, 60% of adults and 31% of children globally are projected to be overweight or obese, a substantial increase from 1990, linked to rising risks of numerous diseases and placing a significant strain on healthcare systems worldwide.
Progress
44% Bias Score


Global Obesity Rise Spurs Infrastructure Overhaul
A study predicts that over half of adults and a third of children worldwide will be overweight or obese by 2050, leading to significant adaptations in various sectors, including hospitals, transport, stadiums, and funeral services to accommodate larger bodies.
Global Obesity Rise Spurs Infrastructure Overhaul
A study predicts that over half of adults and a third of children worldwide will be overweight or obese by 2050, leading to significant adaptations in various sectors, including hospitals, transport, stadiums, and funeral services to accommodate larger bodies.
Progress
24% Bias Score

Brain's Reward System Drives Excessive Sugar Consumption
A study using mice and human brain tissue found that high-sugar diets activate POMC neurons, releasing beta-endorphin, an endogenous opioid, which triggers a reward response, driving increased consumption. This mechanism was also observed in humans using fMRI.

Brain's Reward System Drives Excessive Sugar Consumption
A study using mice and human brain tissue found that high-sugar diets activate POMC neurons, releasing beta-endorphin, an endogenous opioid, which triggers a reward response, driving increased consumption. This mechanism was also observed in humans using fMRI.
Progress
12% Bias Score

France Approves Stricter Nutri-Score Algorithm
The French government approved a stricter Nutri-Score food labeling system despite initial opposition, giving companies two years to adapt packaging to reflect changes designed to combat obesity and improve public health, while remaining vigilant about potential negative effects on some French produ...

France Approves Stricter Nutri-Score Algorithm
The French government approved a stricter Nutri-Score food labeling system despite initial opposition, giving companies two years to adapt packaging to reflect changes designed to combat obesity and improve public health, while remaining vigilant about potential negative effects on some French produ...
Progress
40% Bias Score

China Faces Obesity Crisis: 70% of Adults at Risk
China's National Health Commission warns that without intervention, over 70% of adults and 32% of children will be overweight or obese in five years, driven by lifestyle changes, urbanization, and the rise of fast food; this will cost 22% of all medical expenses by 2030.

China Faces Obesity Crisis: 70% of Adults at Risk
China's National Health Commission warns that without intervention, over 70% of adults and 32% of children will be overweight or obese in five years, driven by lifestyle changes, urbanization, and the rise of fast food; this will cost 22% of all medical expenses by 2030.
Progress
36% Bias Score

Limited Access to Weight Loss Drugs on Scotland's NHS
Currently, in Scotland, only NHS patients with a BMI over 38 and at least one weight-related health condition can access weight loss drugs like Mounjaro and Wegovy due to cost and the scale of obesity; however, private prescriptions are readily available, exceeding one million individuals.

Limited Access to Weight Loss Drugs on Scotland's NHS
Currently, in Scotland, only NHS patients with a BMI over 38 and at least one weight-related health condition can access weight loss drugs like Mounjaro and Wegovy due to cost and the scale of obesity; however, private prescriptions are readily available, exceeding one million individuals.
Progress
36% Bias Score

New Obesity Drugs Achieve Significant Weight Loss, Challenging Traditional Approaches
New drugs, such as semaglutide and tirzepatide, are revolutionizing obesity treatment by mimicking key hormones that regulate appetite and metabolism, achieving significant weight loss (up to 25%) in clinical trials, while traditional methods often fail in the long term; this has led to a surge in p...

New Obesity Drugs Achieve Significant Weight Loss, Challenging Traditional Approaches
New drugs, such as semaglutide and tirzepatide, are revolutionizing obesity treatment by mimicking key hormones that regulate appetite and metabolism, achieving significant weight loss (up to 25%) in clinical trials, while traditional methods often fail in the long term; this has led to a surge in p...
Progress
48% Bias Score

African Women Face Alarming Obesity Rise
A World Obesity Federation study reveals that nearly half of African women will be obese or overweight by 2030, highlighting a critical health crisis exacerbated by limited treatment access, cultural factors, and gender inequalities.

African Women Face Alarming Obesity Rise
A World Obesity Federation study reveals that nearly half of African women will be obese or overweight by 2030, highlighting a critical health crisis exacerbated by limited treatment access, cultural factors, and gender inequalities.
Progress
48% Bias Score
Showing 73 to 84 of 176 results